Book a Demo

Adagene

Home
/
Cases
/
Adagene
Biotech
Multi-GAAP System Integration
Adagene is a platform-driven, clinical-stage biopharmaceutical company (NASDAQ: ADAG) dedicated to discovering and developing novel cancer immunotherapies based on its proprietary antibody technologies. Leveraging its Dynamic Precision Library, Adagene has built a globally leading antibody drug discovery platform. Headquartered in China with a global footprint, the company operates across multiple regions, including the United States and Switzerland.
Project Introduction
Global biopharmaceutical R&D operations require strengthened financial governance across regions. This project establishes automated multi-entity consolidation, integrates CRO procurement and full asset lifecycle management, and supports multi-GAAP reporting. Through OA integration, it unifies R&D, operations, and finance—ensuring compliant, transparent, and globally scalable drug development.
Solutions
Automated Multi-Entity Financial Consolidation CRO Procurement Contract Management End-to-End Procurement, Sales & Inventory Management Fixed Asset Lifecycle Management OA System Integration Multi-GAAP Reporting Support
Project Benefits
Enhanced Global Financial Control Improved Public Company Transparency Increased Global Operational Efficiency Unified Platform to Support Innovation R&D